Global Brachytherapy Market Will Reach USD 441 Million By 2025: Zion Market Research

According to the report, global brachytherapy market was valued at approximately USD 334 million in 2018 and is expected to generate revenue of around USD 441 million by end of 2025, growing at a CAGR of around 4% between 2019 and 2025.


New York, NY, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Childcare Management Software Market by Deployment (On-premise and  Cloud-Based), by Solution(Family and Child Data Management, Time and Activity Management, Nutrition Management, Attendance Tracker, Employee Data Management, Payroll, Accounting, and Others), and by End-user(Parents, Daycare Centers, and Play Schools): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018 - 2026”. According to the report, global brachytherapy market was valued at approximately USD 334 million in 2018 and is expected to generate revenue of around USD 441 million by end of 2025, growing at a CAGR of around 4% between 2019 and 2025.

Brachytherapy is referring to broadly varying processes coupled with changing degrees of invasiveness. Brachytherapy also termed as internal radiation therapy, allows a physician to use a higher dose of radiation for the treatment of smaller area and in a short timespan as compared to the external beam radiation treatment. It is a type of radiation therapy which is used for the treatment of cancer. Radiation therapies generally comprise of different types of energy termed as ionizing radiation, which is used to target and shrink tumors and kill cancer cells. External beam radiation therapy (EBRT) encompasses high-energy X-ray stream of light produced by a machine that is focused at the tumor from outside the body. The brachytherapy includes the introduction of radioactive material right inside or next to the tumor area. 

Browse through 42 Tables & 21 Figures spread over 110 Pages and in-depth TOC on “Global Brachytherapy Market Size & Growth 2017 Report: Industry Share, Growth, Trends, Analysis and Forecast 2025”.

Request Free Sample Report of Global Brachytherapy Market Report @ https://www.zionmarketresearch.com/sample/brachytherapy-market

Cancer is the second most common cause of death in the U.S. According to the American Cancer Society, in 2017, around 600,920 American population died due to cancer. Cancer is one of the foremost reasons for mortality worldwide. There are various types of cancer such as prostate cancer, lung cancer, skin cancer, breast cancer, and colon cancer. Among them, breast cancer is one of the leading types of cancer-causing death, especially in women. Majority of cancer cases are detected and diagnosed when the tumor is seen or felt. Moreover, more than 70% of deaths related to cancer occur in underdeveloped economies in low and middle-income population. Thus, increasing awareness, technological advancement in the treatment of cancer, and extensive R&D will drive the brachytherapy market growth over the forecast period. 

The brachytherapy market is segmented on the basis of technique, application, and by end-user. By technique, the global brachytherapy market is segmented into high dose rate and low dose rate. The high dose rate segment accounted for the major share in the global brachytherapy market in 2017. The growth can be attributed to technological developments, the introduction of novel products, and massive applications.

Download Free Report PDF Brochure: https://www.zionmarketresearch.com/requestbrochure/brachytherapy-market

Cervical cancer, prostate cancer, breast cancer, skin cancer, and others are the key applications of the brachytherapy market. The prostate cancer segment dominated the market in terms of revenue in 2017. On the other hand, the breast cancer segment is anticipated to register the highest CAGR in the global brachytherapy market, owing to the increasing prevalence of breast cancer across the globe.

On the basis of end-user, the global brachytherapy market is segmented into hospitals and oncology treatment centers. The hospital's segment is estimated to dominate the global brachytherapy market during the forecast period. The oncology treatment centers segment is anticipated to grow with highest CAGR in global brachytherapy market.

Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/brachytherapy-market

North America holds a significant share of the brachytherapy market. The region is anticipated to see substantial growth in the coming years, owing to massive presence of prominent market players in the region and high adoption of technically advanced cancer treatment methods. In addition, acceptance of efficient and safer cancer treatment procedures along with high prevalence of cancer among the population will further drive the regional growth.  The U.S. is expected to dominate the North America brachytherapy market. Also the U.S. market is expected to grow at a highest growth rate throughout the forecast period. This progress is mainly attributed to high prevalence rate of cancer and well-developed healthcare systems. According to the study of American Cancer Society, in 2018 above 2 million new cancer cases were predicted to be diagnosed in the U.S.. The healthcare developments taking place across the U.S. along with enhanced coverage and access for the residents is increasing efficiency of the healthcare system in the country.

Europe is anticipated to secure the second largest regional market share and is likely to show noteworthy growth in the years to come. This growth is mainly due to the changing demographics and increasing incidence of cancer in the region. Therefore, the treatment via radiotherapy is estimated to be the most preferred option in the region. In Europe, maximum focus is on the issue of healthcare quality and efficiency. In 2017, according to the Europe Cancer Research near about 11,287 deaths were reported due to prostate cancer in the UK. In the established regions, prostate cancer is the most common reason of death. According to the EU Science Hub statistics, by 2018, the region was estimated to witness nearly 3.9 million new cancer cases and above 1.9 million deaths due to cancer in Europe.

Browse the full “Childcare Management Software Market by Deployment (On-premise and  Cloud-Based), by Solution(Family and Child Data Management, Time and Activity Management, Nutrition Management, Attendance Tracker, Employee Data Management, Payroll, Accounting, and Others), and by End-user(Parents, Daycare Centers, and Play Schools): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018 - 2026” Report at https://www.zionmarketresearch.com/report/brachytherapy-market

Asia Pacific is anticipated to witness a lucrative growth in the near future. In the Asia Pacific, China, India, and Japan will continue to be the key business destinations as well as regional revenue contributors for brachytherapy market. Growth in Asia Pacific market is expected to be driven by high burden of disease, limited access to technology, and advanced treatment for cancer coupled with increasing awareness of cancer among the people.

Latin America is also an emerging market and is anticipated to show moderate growth by the end of forecast period. Among the Middle East & Africa market, the African countries are projected to have noticeable growth, owing to increasing cancer prevalence along with the introduction of new government initiatives.

Request customized copy of report @ https://www.zionmarketresearch.com/custom/3796

Some of the key players in global brachytherapy market include Eckert & Ziegler BEBIG, IsoRay Medical, Inc., Carl Zeiss Meditec AG, Argon Medical Devices Inc., Panacea Medical Technologies, Elekta AB, Boston Scientific Corporation, CR Bard Inc., GE Healthcare, and Varian Medical Systems, Inc., among others.

Request for Discount: https://www.zionmarketresearch.com/requestdiscount/brachytherapy-market

Global Brachytherapy Market: Technique Segment Analysis

  • High Dose Rate
  • Low Dose Rate 

Global Brachytherapy Market: Application Segment Analysis

  • Cervical Cancer
  • Prostate Cancer
  • Breast Cancer
  • Skin Cancer 
  • Others 

Global Brachytherapy Market: End-User Segment Analysis

  • Hospitals
  • Oncology Treatment Centers 

Global Brachytherapy Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Related Reports:

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research

Blog: http://usindustrynews.com | http://europeindustrynews.com | http://zmrresearchnews.us | http://zmrmarketjournal.com

Contact Us:

Joel John
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com

Website: https://www.zionmarketresearch.com

Blog: http://zmrblog.com